Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash from Financing Activities (2018 - 2026)

Tenax Therapeutics' Cash from Financing Activities history spans 6 years, with the latest figure at -$100160.0 for Q4 2015.

  • On a quarterly basis, Cash from Financing Activities changed N/A to -$100160.0 in Q4 2015 year-over-year; TTM through Sep 2016 was -$100160.0, a 100.18% decrease, with the full-year FY2025 number at $38.5 million, down 61.44% from a year prior.
  • Cash from Financing Activities hit -$100160.0 in Q4 2015 for Tenax Therapeutics, down from -$48209.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TENX hit a ceiling of $55.0 million in Q2 2014 and a floor of -$298988.0 in Q2 2015.
  • Historically, Cash from Financing Activities has averaged $4.7 million across 5 years, with a median of $1.0 million in 2011.
  • Biggest five-year swings in Cash from Financing Activities: crashed 102.3% in 2012 and later soared 7057.26% in 2014.
  • Tracing TENX's Cash from Financing Activities over 5 years: stood at $610550.0 in 2011, then crashed by 102.3% to -$14027.0 in 2012, then soared by 3798.85% to $518838.0 in 2013, then plummeted by 62.14% to $196437.0 in 2014, then crashed by 150.99% to -$100160.0 in 2015.
  • Business Quant data shows Cash from Financing Activities for TENX at -$100160.0 in Q4 2015, -$48209.0 in Q3 2015, and -$298988.0 in Q2 2015.